SCHEMBL19782078

SCHEMBL19782078

Cc1cccc(F)c1-c1ncc[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 2/20 0.44
F2RL1 P55085 3/20 0.44
TAAR1 Q96RJ0 1/20 0.44
MTOR P42345 1/20 0.43
ADK P55263 1/20 0.43
ALDH1A1 P00352 4/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ACHE P22303 1/20 0.38
MC4R P32245 1/20 0.38
CSNK1A1 P48729 1/20 0.37
TYRO3 Q06418 1/20 0.37
DYRK1B Q9Y463 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
MGAM O43451 1/20 0.36
GAA P10253 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
BRD4 O60885 1/20 0.36
ADORA2A P29274 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6001368 0.87 NISCH (0.52) NISCHF2RL1TAAR1MTORADK
SCHEMBL6002691 0.87 NISCH (0.50) NISCHF2RL1TAAR1MTORADK
Hydrochloric Acid SCHEMBL29265356 0.85 NISCH (0.50) NISCHF2RL1TAAR1MTORADK
SCHEMBL28766417 0.82 NISCH (0.47) NISCHF2RL1TAAR1MTORADK
SCHEMBL22096835 0.82 TAAR1 (0.49) NISCHF2RL1TAAR1MTORADK
SCHEMBL9260794 0.81 NISCH (0.46) NISCHF2RL1TAAR1MTORADK
SCHEMBL28829249 0.79 NISCH (0.43) NISCHF2RL1MTORADKALDH1A1
SCHEMBL21883582 0.79 NISCH (0.40) NISCHF2RL1TAAR1MTORADK
SCHEMBL19769010 0.79 TAAR1 (0.48) NISCHF2RL1TAAR1MTORADK
SCHEMBL14886293 0.79 CSNK1A1 (0.54) NISCHF2RL1TAAR1MTORADK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10875839-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2020-12-29 US disclosed
US-20200190053-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2020-06-18 US disclosed
US-10351547-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2019-07-16 US disclosed
US-20190002431-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2019-01-03 US disclosed
WO-2018013676-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. (US) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200190053-A1 SOMATOSTATIN MODULATORS AND USES THEREOF SSTR5, SSTR2, SSTR4 NISCH 599/4885F2RL1 2624/4885TAAR1 415/4885
US-10351547-B2 Somatostatin modulators and uses thereof SSTR5, SSTR2, SSTR4 NISCH 599/4885F2RL1 2624/4885TAAR1 415/4885
US-20190002431-A1 SOMATOSTATIN MODULATORS AND USES THEREOF SSTR5, SSTR2, SSTR4 NISCH 599/4885F2RL1 2624/4885TAAR1 415/4885
US-10875839-B2 Somatostatin modulators and uses thereof SSTR5, SSTR2, SSTR4 NISCH 599/4885F2RL1 2624/4885TAAR1 415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.